Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Recruitment Status: Completed"
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=3
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=3
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=3
PubPharm (1.580)
21
RANDOMIZED STUDY OF STAGE THALIDOMIDE (NSC 66847) MORE DEXAMETHASONE, VERSUS DEXAMETHASONE IN PATIENTS WITH RECENT DIAGNOSIS OF MULTIPLE MYELOMA. : RANDOMIZED STUDY OF STAGE THALIDOMIDE (NSC 66847) MORE DEXAMETHASONE, VERSUS DEXAMETHASONE IN PATIENTS WITH RECENT DIAGNOSIS OF MULTIPLE MYELOMA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
22
A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO HIGH-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (SIROCCO) : A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF BENRALIZUMAB (MEDI-563) ADDED TO HIGH-DOSE INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST IN PATIENTS WITH UNCONTROLLED ASTHMA (SIROCCO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
23
PLACEBO CONTROLLED EFFICACY AND SAFETY STUDY OF MOMETHASONE FUROATE ADMINISTERED BY DRY POWDER INHALER IN THE TREATMENT OF ASTHMA IN CHILDREN PREVIOUSLY MAINTAINED WITH INHALED CORTICOSTEROIDS : PLACEBO CONTROLLED EFFICACY AND SAFETY STUDY OF MOMETHASONE FUROATE ADMINISTERED BY DRY POWDER INHALER IN THE TREATMENT OF ASTHMA IN CHILDREN PREVIOUSLY MAINTAINED WITH INHALED CORTICOSTEROIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
24
CORTICOSTEROID RANDOMISATION AFTER SIGNIFICANT HEAD INJURY : CORTICOSTEROID RANDOMISATION AFTER SIGNIFICANT HEAD INJURY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
25
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting : PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE INTRAVENOUS AND ORAL FORMULATIONS OF THE ANTAGONIST RECEPTOR OF NEUROKININ-1, CASOPITANT (GW679769) IN COMBINATION WITH ONDANSETRON AND DEXAMETHASONE FOR PREVENTION OF NAUSEA AND VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
26
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
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
27
A 52-WEEK, MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TRALOKINUMAB IN ADULTS AND ADOLESCENTS WITH ASTHMA INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID PLUS LONG-ACTING β2-AGONIST (D2210C00007) : A 52-WEEK, MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TRALOKINUMAB IN ADULTS AND ADOLESCENTS WITH ASTHMA INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID PLUS LONG-ACTING β2-AGONIST (D2210C00007)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
28
MULTIPLE COURSES OF ANTENATAL CORTICOSTEROIDS FOR PRETERM BIRTH STUDY (MACS) : MULTIPLE COURSES OF ANTENATAL CORTICOSTEROIDS FOR PRETERM BIRTH STUDY (MACS)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
29
A 52-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLEDUMMY, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF FEVIPIPRANT ONCE DAILY PLUS STANDARD-OF-CARE (SOC) FORREDUCTION OF SYSTEMIC CORTICOSTEROIDS (ORAL AND PARENTERAL) USE IN PATIENTS WITH SEVERE ASTHMA : A 52-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLEDUMMY, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF FEVIPIPRANT ONCE DAILY PLUS STANDARD-OF-CARE (SOC) FORREDUCTION OF SYSTEMIC CORTICOSTEROIDS (ORAL AND PARENTERAL) USE IN PATIENTS WITH SEVERE ASTHMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
30
A MULTICENTRE, RANDOMIZED, PARALLEL GROUP, PHASE 3 SAFETY EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF BENRALIZUMAB (MEDI-563) IN ASTHMATIC ADULTS AND ADOLESCENTS ON INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST (BORA) : A MULTICENTRE, RANDOMIZED, PARALLEL GROUP, PHASE 3 SAFETY EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF BENRALIZUMAB (MEDI-563) IN ASTHMATIC ADULTS AND ADOLESCENTS ON INHALED CORTICOSTEROID PLUS LONG-ACTING β2 AGONIST (BORA)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[158]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Recruitment Status: Completed
Filter aufheben
Thema: Study Type: Interventional
Medienart
1.580
Aufsätze
1.580
E-Artikel
1.580
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.580
610
Recruitment Status: Completed
Study Type: Interventional
162
Phase: Phase 2/Phase 3
136
Phase: Phase 4
94
Phase: Phase 3
62
Phase: Phase 2
46
Phase: Phase 1
22
Phase: Other
20
Medical Condition: Multiple Myeloma
16
Medical Condition: -J45;J45
16
Medical Condition: Asthma; Asthma;Respiratory -...
14
Medical Condition: ;Diseases of the musculo-ske...
14
Medical Condition: Health Condition 1: O- Medic...
14
Phase: Phase 3/Phase 4
12
Phase: Post-market
10
Medical Condition: ;Not Applicable
10
Phase: Phase 1/Phase 2
8
Medical Condition: Anaesthesia;Anaesthesia
8
Medical Condition: Asthma Respiratory Asthma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
864
2020-
716
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.544
Englisch
34
Unbestimmt
2
Niederländisch
Haven't found what you're looking for?
Wird geladen...